tradingkey.logo

Penumbra jumps on Boston Scientific's $14.5 billion buyout deal

ReutersJan 15, 2026 1:26 PM

Shares of medical equipment maker Penumbra PEN.N rise 13.6% to $356 premarket

Boston Scientific says it will buy Penumbra in a deal valued at about $14.5 billion

The transaction values each Penumbra share at $374, a premium of 19.3% to the stock's last close

Boston Scientific BSX.N falls 4.10% to $89.90 premarket

The deal is expected to be completed later this year

BSX shares rose 6.75%, PEN rose 29.6% in 2025

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI